Tuesday, May 05, 2015 10:01:05 PM
They can short all they want, it doesn't end well for them. People aren't used to this type of momentum. There about to schooled over the next couple months. Fighting soros is like fighting the government, endless resources, so go against the grain on your thinking this time around. I am looking forward to the short traps and the words uncle when this all pays out. Again, outstanding trade. You read this well last week when the sheep followed their leader. Those sheep created a incredible buying opportunity. Different sheep from a different heard will create a much bigger opportunity.
Recent ABEO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 12:47:16 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 04/07/2026 12:45:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 12:35:30 PM
- Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors • GlobeNewswire Inc. • 04/07/2026 12:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 04/06/2026 10:00:19 PM
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 04/06/2026 12:30:00 PM
- Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in New York • GlobeNewswire Inc. • 04/02/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 01:03:36 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/31/2026 08:42:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/20/2026 08:30:37 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/17/2026 11:36:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/17/2026 11:30:18 AM
- Abeona Therapeutics® Reports Full Year 2025 Financial Results and Corporate Updates • GlobeNewswire Inc. • 03/17/2026 11:30:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/16/2026 08:31:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 08:29:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/09/2026 11:30:53 AM
- Abeona Therapeutics® Provides Business Update Highlighting Building Momentum in ZEVASKYN® Commercial Launch • GlobeNewswire Inc. • 03/09/2026 11:30:00 AM
- Abeona Therapeutics® Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/09/2026 09:01:29 PM
- Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 02/09/2026 03:04:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:30:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2026 11:59:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/02/2026 11:55:32 PM
